Home › Funds › Zurich Insurance Group Ltd/FI › ABT

Zurich Insurance Group Ltd/FI position in ABT

ABBOTT LABORATORIES · Health Care

Zurich Insurance Group Ltd/FI reported holding 677,392 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$66.9M, representing 0.47% of its reported portfolio and ranking #44 among its reported holdings. Zurich Insurance Group Ltd/FI has disclosed ABT holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)677.39K sh
Reported value held$66.95M
Portfolio Weight0.47%
First reportedQ1 2024
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Zurich Insurance Group Ltd/FI's ABT position evolved

Zurich Insurance Group Ltd/FI first disclosed a stake in ABT in Q1 2024 at 19,000 shares (US$2.2M). The position peaked in Q1 2025 at 1,115,514 shares, worth US$148.0M. Across 11 filings, Zurich Insurance Group Ltd/FI increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 677,392 shares valued at US$66.9M — an increase of 376,682 shares quarter over quarter.. Notable position changes include a 5771% increase in Q1 2025 (shares rose 3% over the following quarter), a 1483% increase in Q2 2026 (shares rose 10% over the following quarter), a 125% increase in Q3 2026 (shares rose 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 19.00K $2.16M New
Q2 2024 19.00K $1.97M Hold
Q3 2024 19.00K $2.17M Hold
Q4 2024 19.00K $2.15M Hold
Q1 2025 1.12M $147.97M Add
Q2 2025 864.71K $117.61M Reduce
Q3 2025 19.00K $2.54M Reduce
Q4 2025 19.00K $2.38M Hold
Q1 2026 19.00K $1.95M Hold
Q2 2026 300.71K $27.29M Add
Q3 2026 677.39K $66.95M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.65B), Charles Schwab Investment Management (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Zurich Insurance Group Ltd/FI held ABT?

Zurich Insurance Group Ltd/FI has disclosed ABT holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is Zurich Insurance Group Ltd/FI's current position in ABT?

As of Q3 2026, Zurich Insurance Group Ltd/FI holds 677.39K shares of ABT (ABBOTT LABORATORIES), valued at $66.95M, representing 0.47% of its reported portfolio and ranking #44.

Has Zurich Insurance Group Ltd/FI been buying or selling ABT?

In the latest 13F filing (Q3 2026), Zurich Insurance Group Ltd/FI increased its position in ABT. The position peaked in Q1 2025 at 1.12M shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, Charles Schwab Investment Management, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.